Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
AEMT Medications
| Question | Answer |
|---|---|
| pharmacodynamics of Albuterol? | ß Agonist with preference for ß2 receptors. |
| indications of Albuterol? | Bronchospasm, Anaphylaxis, hyperkalemia |
| contraindications of Albuterol? | Hypersensitivity |
| dose of Albuterol? | Bronchospasm: 2.5 mg/3 mL's via SVN q15-20 mins. Hyperkalemia: 10-20 mg via LVN over 15 minutes |
| What is the pharmacodynamics of Activated Charcoal? | Binds and adsorbs toxic substances in the digestive tract |
| Indications of Activated Charcoal? | Most oral poisonings/overdoses |
| contraindications of Activated Charcoal? | ↓ LOC, OD of corrosives, caustics, petroleum substances |
| Dose of Activated Charcoal? | PO: 1-2 g/kg |
| Pharmacodynamics of Aspirin? | Blocks Cyclooxygenase (an enzyme that is basically an alarm for the body). COX acts upon Arachidonic Acid which in turn generates Thromboxane A2, a compound that regulates the activation of platelets to form a clot. |
| Indications of Aspirin? | Cardiac signs/symptoms with ischemic etiology / suspected MI |
| Contraindications of Aspirin? | Allergy to medication. Bronchospasm, Angioedema. |
| Dose for Aspirin? | 160-325 mg PO of non-enteric coated ASA. |
| Pharmacodynamics of Dextrose 50% | Electrolyte / Carbohydrate. Water-soluble monosaccharide |
| Indications of Dextrose 50% | Correction of hypoglycemia |
| Contraindications of Dextrose 50% | Known hyperglycemia |
| Dose for Dextrose 50% | D50: 25 grams IV/IO, D10 in 50 mL (5 grams) IV/IO boluses (max 250 mL) |
| Pharmacodynamics for Epinephrine 1:1,000 and Epinephrine 1:10,000 | Sympathetic agonist. Powerful α and ß agonist. |
| Indications for Epi 1:1,000 | Severe bronchospasm, Allergies/anaphylaxis |
| Indications for Epi 1: 10,000 | Cardiac arrest |
| Contraindications for Epi | Few, weight risks vs benefits. |
| Dose for Epi 1:1,000 | 0.01 mg/kg IM (max 0.3 mg) |
| Dose for Epi 1:10,000 | 1 mg IVP/IOP q3-5 mins |
| Pharmacodynamics for Glucagon | Hormone. Binds to Glucagon receptors and stimulates adenyal cyclase, which increases cAMP |
| Indications for Glucagon | Hypoglycemia |
| Contraindications for glucagon | Hypersensitivity |
| Dose for Glucagon | 1 mg IM |
| Pharmacodynamics for Ipratropium (Atrovent) | Anticholinergic. Selectively blocks muscarinic receptors. |
| Indications for Ipratropium (Atrovent) | Bronchospasm associated with obstructive lung diseases (asthma, COPD) |
| Contraindications for Ipratropium (Atrovent) | Hypersensitivity |
| Dose for Ipratropium (Atrovent) | 500 mcg/2.5 mL via SVN |
| Pharmacodynamics of Narcan | Opiate Antagonist |
| Indications for Narcan | Suspected Opiate overdose with respiratory depression |
| Contraindications for Narcan | Hypersensitivity |
| Dose for Narcan | 0.4-2 mg IV/IO/IM/IN |
| Pharmacodynamics for Nitroglycerin | Nitrate. Potent vasodilator that opens coronary vessels to improve blood flow to the myocardium. Decreases overall workload of the heart and afterload. |
| indications for Nitroglycerin | Symptoms suggestive of myocardial ischemia, CHF. |
| Contraindications for Nitroglycerin | Hypotension (SBP <90 mmHg), Severe bradycardia (<50 BPM), Tachycardia (>100 BPM), RVI, Use of phosphodiesterase inhibitors last 48 hours), Increased ICP. |
| Dose for Nitroglycerin | 0.4 mg tablet or spray - repeat X 3 (q5 minutes) for a total max dose 1.2 mg. |
| Pharmacodynamic of Ondansetron (Zofran) | Selective serotonin 5-HT3 receptor blocker. |
| Indications for Ondansetron (Zofran) | Prevention and control of Nausea and/or vomiting. |
| Contraindications for Ondansetron (Zofran) | Hypersensitivity |
| Dose for Ondansetron (Zofran) | 4-8 mg IV slow push, IM, PO. |
Created by:
Trigsmom